MKI67 and ductal breast carcinoma in situ: For the time being, their role in DCIS is exploratory and needs to be placed into a broader context to inform the management (for instance, PBI to small, low/intermediate-grade DCIS not overexpressing HER2 and omission of RT for luminal A-like DCIS with KI-67 < 10%).